Newsbenzinga
Tvardi Therapeutics Increases At-The-Market Offering Program To $9.69M In Shares
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…